Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Therapy Methods and Clinical Development is Scopus-indexed (Q1, CiteScore 7.7), DOAJ. Published by Cell Press.
Checked against the index lists dated .
ISSN 2329-0501Verify ISSN ↗
Publisher: Cell Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 71 / 357 | 80th | Q1 |
| Molecular Biology | 119 / 414 | 71st | Q2 |
| Molecular Medicine | 52 / 179 | 71st | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–2025, best quartile Q1, CiteScore 7.7.
Molecular Therapy Methods and Clinical Development is Q1 in Genetics (rank 71 of 357), Q2 in Molecular Biology (rank 119 of 414) and Q2 in Molecular Medicine (rank 52 of 179), by CiteScore 2025.
Molecular Therapy Methods and Clinical Development is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 7.7, quartile Q1, 80th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.749, quartile Q1, with an H-index of 77.
The publisher lists an article processing charge of about US$3,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Therapy Methods and Clinical Development is published by Cell Press. Its ISSN is 2329-0501.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Molecular Therapy Methods and Clinical Development has an h-index of 93 and a 2-year mean of 6.78 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #28 of 353 Scopus journals in Genetics.
Molecular Therapy Methods and Clinical Development published 230 papers in 2025; its busiest recent year was 2020 with 252. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025), authors are most often from United States (48.2%), Canada (7.5%) and France (5.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.